Search

everythinglearnresearchcommunity

for

Search:↓

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Transplant success has improved with better immunosuppressive drugs and donor matching.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

The study identified key immune cell differences between mild and severe alopecia areata.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Immune cells help keep skin healthy and repair it, but imbalance can cause disease.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Cells from the lower part of hair follicles are a promising, less invasive option for immune system therapies.

iNKT cells help develop and maintain healthy skin in young mice.

Different immune cells like platelets, mast cells, neutrophils, macrophages, T cells, B cells, and innate lymphoid cells all play roles in skin wound healing, but more research is needed due to inconsistent results and the complex nature of the immune response.

Mesenchymal stem cells and their vesicles may effectively treat skin diseases, but more research is needed.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.